We know that over 600 million people suffer with chronic lower back pain worldwide.

We know that it is amongst the leading burdens of disease globally, causing significant mental anguish and astronomical economic losses.

We know that often, it affects people in their prime, leaving them unable to connect with loved ones, engage in fulfilling work, or even feel the joy of living.

We know that this will only get worse as systemic factors will increase the number of those affected and reduce people’s access to healthcare.

We know that current therapies only offer short term pain relief, and spine surgery is a scary prospect, looming at the end of years of pain.

If you are a person with Chronic Back Pain due to Degenerated Disc Disease and you, VitaDisc® may be for you. VitaDisc® is currently in the preclinical phase, that means it is currently undergoing in-vitro and in-vivo studies to make sure it is safe before it is administered to human patients in a clinical trial at a later date.

We cannot anticipate when exactly the clinical (human) trials will start, but if you are interested in being contacted in the preparatory phase, please email patients@ncbiomatrix.com.

Please do not send us any personal clinical information or imaging as we cannot take responsibility for storing this at this time, nor can we ever give a medical opinion on your clinical options.